Press "Enter" to skip to content

Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pill

Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.

Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *